Mark Cohen Net Worth & Insider Trades

Mark Cohen - Director, Akari Therapeutics Plc

As of June 30, 2016

What is Mark Cohen's Net Worth?

The current estimated net worth of Akari Therapeutics Plc's Director, Mark Cohen, is estimated to be about $2.38K . Mark Cohen owns about 1,055,600 units of Akari Therapeutics Plc common stock. In the last year at Akari Therapeutics Plc, Mark Cohen has sold an estimated value of $0 worth.

What is Mark Cohen's Past Insider Trading?

Mark Cohen's largest purchase order was 1,055,600 units , worth over $200.04K on September 22, 2015. In total, Mark Cohen has made about 3 transactions over a year of their time at Akari Therapeutics Plc. Mark Cohen usually trades in June, September and November, with the busiest year in 2015.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Mark Cohen's' Mailing Address?

  • Mailing address is C/o Celsus Therapeutics Plc 24 West 40th Street New York NY 10018 NY

What are Akari Therapeutics Plc's Past Insider Trades?

Akari Therapeutics Plc's most recent insider trade came on September 22, 2015 by Mark Cohen who bought 1,055,600 units worth $200.04K . In the years Akari Therapeutics Plc was active, insiders at Akari Therapeutics Plc have bought an estimated value of $0 worth of shares. Insider trading is most common in September, with the busiest year in 2015. The most active traders at the company are James Hill, Director,  Mark Cohen, Director,  and Stuart Ungar, Director .

Akari Therapeutics Plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1